Tudóstér: Kacsir István publikációi

Kacsir, I., Sipos, A., Kiss, T., Major, E., Bajusz, N., Tóth, E., Buglyó, P., Somsák, L., Kardos, G., Bai, P., Bokor, É.: Half sandwich-type osmium, ruthenium, iridium and rhodium complexes with bidentate glycosyl heterocyclic ligands induce cytostasis in platinum-resistant ovarian cancer cells and bacteriostasis in Gram-positive multiresistant bacteria.
Front. Chem. 11 1-18, 2023.

Kacsir, I., Sipos, A., Major, E., Bajusz, N., Bényei, A., Buglyó, P., Somsák, L., Kardos, G., Bai, P., Bokor, É.: Half-sandwich type platinum-group metal complexes of C-Glucosaminyl azines: syntheses, antineoplastic and antimicrobial activities.
Molecules. 28 (7), 1-55, 2023.

Kacsir, I., Sipos, A., Bényei, A., Janka, E., Buglyó, P., Somsák, L., Bai, P., Bokor, É.: Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models.
Int. J. Mol. Sci. 23 (2), 1-39, 2022.

Balázs, B., Tóth, Z., Kacsir, I., Sipos, A., Buglyó, P., Somsák, L., Bokor, É., Kardos, G., Bai, P.: Targeting multiresistant Gram-positive bacteria by ruthenium, osmium, iridium and rhodium half-sandwich type complexes with bidentate monosaccharide ligands.
Front. Chem. 10 1-9, 2022.

Nagy, S., Tóth, E., Kacsir, I., Makai, A., Bényei, A., Buglyó, P.: Effect of the replacement of tripodal 4N donors by two 2N chelators on the redox and cytotoxic activity of maltolato and deferipronato containing Co(III) complexes.
J. Inorg. Biochem. 220 1-10, 2021.

Kacsir, I., Sipos, A., Ujlaki, G., Buglyó, P., Somsák, L., Bai, P., Bokor, É.: Ruthenium half-sandwich type complexes with bidentate monosaccharide ligands show antineoplastic activity in ovarian cancer cell models through reactive oxygen species production.
Int. J. Mol. Sci. 221 1-41, 2021.

Sanna, D., Ugone, V., Buglyó, P., Nagy, S., Kacsir, I., Garribba, E.: Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [V IV O(oda)(H 2 O) 2 ], a V compound with in vitro anticancer activity.
Inorg. Chim. Acta. 472 127-138, 2018.

Buglyó, P., Kacsir, I., Kozsup, M., Nagy, I., Nagy, S., Bényei, A., Kováts, É., Farkas, E.: Tuning the redox potentials of ternary cobalt(III) complexes containing various hydroxamates.
Inorg. Chim. Acta. 472 234-242, 2018.